Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kinsella

Showing results (471-480 of 501) with videos related to

Pageof 51
Sort By:
Cancer Research|November 24, 2001
Loss of DNA mismatch repair imparts defective cdc2 signaling and G(2) arrest responses without altering survival after ionizing radiationT Yan, J E Schupp, H S Hwang, et al.
Blood|May 1, 1993
Adjuvant immunotoxin therapy with anti-B4-blocked ricin after autologous bone marrow transplantation for patients with B-cell non-Hodgkin's lymphomaM L Grossbard, J G Gribben, A S Freedman, et al.
Cancer Research|March 4, 1998
Defective expression of the DNA mismatch repair protein, MLH1, alters G2-M cell cycle checkpoint arrest following ionizing radiationT W Davis, C Wilson-Van Patten, M Meyers, et al.
American Journal of Clinical Oncology|October 8, 2008
The impact of resection margin status and postoperative CA19-9 levels on survival and patterns of recurrence after postoperative high-dose radiotherapy with 5-FU-based concurrent chemotherapy for resectable pancreatic cancerTimothy J Kinsella, Yuji Seo, Joseph Willis, et al.
Journal of Visualized Experiments : Jove|December 2, 2024
Improving Student Outcomes with an Adaptable Molecular Cloning Course-Based Undergraduate Research ExperienceChristopher B Cummings, Samuel S Catania, Eirene M Q Ednacot, et al.
International Journal of Radiation Oncology, Biology, Physics|October 15, 1994
National Cancer Institute (phase II) study of high-grade glioma treated with accelerated hyperfractionated radiation and iododeoxyuridine: results in anaplastic astrocytomaF J Sullivan, L L Herscher, J A Cook, et al.
Frontiers in Oncology|December 11, 2013
A Predictive Genetic Signature for Response to Fluoropyrimidine-Based Neoadjuvant Chemoradiation in Clinical Stage II and III Rectal CancerJason Chan, Michael T Kinsella, Joseph E Willis, et al.
International Journal of Radiation Oncology, Biology, Physics|September 6, 2003
Four-year biochemical outcome after radioimmunoguided transperineal brachytherapy for patients with prostate adenocarcinomaRodney J Ellis, Amy Vertocnik, Edward Kim, et al.
Infection Control and Hospital Epidemiology|August 5, 2020
Seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a London NHS TrustJoseph J Grant, Stephanie M S Wilmore, Naina S McCann, et al.
The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland|February 5, 2026
Trends in incidence, management and survival in medullary thyroid cancer in Ireland - A 25-year population-based studyT J Crotty, G P Sexton, E F Cleere, et al.
Pageof 51

Showing results (471-480 of 501) with videos related to

Sort By:
Pageof 51
Cancer Research|November 24, 2001
Loss of DNA mismatch repair imparts defective cdc2 signaling and G(2) arrest responses without altering survival after ionizing radiationT Yan, J E Schupp, H S Hwang, et al.
Blood|May 1, 1993
Adjuvant immunotoxin therapy with anti-B4-blocked ricin after autologous bone marrow transplantation for patients with B-cell non-Hodgkin's lymphomaM L Grossbard, J G Gribben, A S Freedman, et al.
Cancer Research|March 4, 1998
Defective expression of the DNA mismatch repair protein, MLH1, alters G2-M cell cycle checkpoint arrest following ionizing radiationT W Davis, C Wilson-Van Patten, M Meyers, et al.
American Journal of Clinical Oncology|October 8, 2008
The impact of resection margin status and postoperative CA19-9 levels on survival and patterns of recurrence after postoperative high-dose radiotherapy with 5-FU-based concurrent chemotherapy for resectable pancreatic cancerTimothy J Kinsella, Yuji Seo, Joseph Willis, et al.
Journal of Visualized Experiments : Jove|December 2, 2024
Improving Student Outcomes with an Adaptable Molecular Cloning Course-Based Undergraduate Research ExperienceChristopher B Cummings, Samuel S Catania, Eirene M Q Ednacot, et al.
International Journal of Radiation Oncology, Biology, Physics|October 15, 1994
National Cancer Institute (phase II) study of high-grade glioma treated with accelerated hyperfractionated radiation and iododeoxyuridine: results in anaplastic astrocytomaF J Sullivan, L L Herscher, J A Cook, et al.
Frontiers in Oncology|December 11, 2013
A Predictive Genetic Signature for Response to Fluoropyrimidine-Based Neoadjuvant Chemoradiation in Clinical Stage II and III Rectal CancerJason Chan, Michael T Kinsella, Joseph E Willis, et al.
International Journal of Radiation Oncology, Biology, Physics|September 6, 2003
Four-year biochemical outcome after radioimmunoguided transperineal brachytherapy for patients with prostate adenocarcinomaRodney J Ellis, Amy Vertocnik, Edward Kim, et al.
Infection Control and Hospital Epidemiology|August 5, 2020
Seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a London NHS TrustJoseph J Grant, Stephanie M S Wilmore, Naina S McCann, et al.
The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland|February 5, 2026
Trends in incidence, management and survival in medullary thyroid cancer in Ireland - A 25-year population-based studyT J Crotty, G P Sexton, E F Cleere, et al.
Pageof 51